QLT, Inc. (QLTI) Reports In-Line Q1 EPS

QLT, Inc. (NASDAQ: QLTI) reported Q1 EPS of ($0.13), in-line with the analyst estimate of ($0.13).

As at March 31, 2014, the Company's consolidated cash and cash equivalents was $139.9 million compared to $118.5 million of cash and cash equivalents at the end of 2013. The increase was primarily due to $28.1 million of proceeds received from Tolmar in connection with Eligard related contingent consideration, which included the $17.0 million related to the Consent and Amendment Agreement discussed under the QLT Expenses / Other Income section above. In addition, we have approximately $10.0 million of Eligard related contingent consideration still owing to us under the terms of the 2009 Stock Purchase Agreement, which is expected to be collected in full on or before November 30, 2014.

For earnings history and earnings-related data on QLT, Inc. (QLTI) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c